Kang Pauline
School of Optometry and Vision Science, The University of New South Wales, Sydney, New South Wales, Australia.
Clin Exp Optom. 2018 May;101(3):321-332. doi: 10.1111/cxo.12666. Epub 2018 Feb 28.
Recent increases in global myopia prevalence rates have raised significant concerns as myopia increases the lifelong risk of various sight-threatening ocular conditions. This growing public health burden has generated significant research interests into understanding both its aetiology and developing effective methods to slow down or stop its development, methods collectively termed 'myopia control'. The growing body of research has demonstrated benefits of various optical and pharmacological treatments resulting in myopia control management increasingly becoming a part of main stream clinical practice. This review will discuss the peer-reviewed literature on the efficacy of various myopia control interventions including multifocal spectacles and contact lenses, orthokeratology and pharmaceutical eye drops, as well as potential future research directions.
近期全球近视患病率的上升引发了人们的重大担忧，因为近视会增加患各种威胁视力的眼部疾病的终生风险。这种日益加重的公共卫生负担激发了大量研究兴趣，旨在了解近视的病因，并开发有效的方法来减缓或阻止其发展，这些方法统称为“近视控制”。越来越多的研究表明，各种光学和药物治疗都有效果，这使得近视控制管理日益成为主流临床实践的一部分。本综述将讨论经同行评审的文献，内容涉及各种近视控制干预措施的疗效，包括多焦点眼镜和隐形眼镜、角膜塑形术和眼药水，以及未来潜在的研究方向。
